Market Overview

The Global Cell Therapy Market was valued at USD 6,167.6 million in 2023 and is expected to reach USD 20,927.9 million by 2031 while growing at a CAGR of 16.5% during the forecast period (2024-2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global cell therapy market growth. Cell therapy, also referred to as cellular or cytotherapy, utilizes living cells to prevent, treat, or potentially cure diseases. The core concept is to leverage cells' unique properties for therapeutic purposes, employing various types like stem cells and immune cells. These cells are sourced from the patient, a donor, or a cell line.

With the rising prevalence of chronic diseases and advancements in cellular biology and technology, the Cell Therapy market is poised for substantial growth. However, obstacles such as high development costs and a lack of standardization in cell therapy manufacturing processes may impede market expansion.

Furthermore, the global cell therapy industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Type Analysis

The Global Cell Therapy Market is segmented among Autologous, and Allogeneic, based on Type. In 2023, Autologous accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Therapy Analysis

The Global Cell Therapy Market is segmented among Mesenchymal Stem Cell Therapy, Fibroblast Cell Therapy, Hematopoietic Stem Cell Therapy, and Other Therapies, based on Therapy. In 2023, Hematopoietic Stem Cell Therapy accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Cell Therapy Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Anterogen Co. Ltd, Tego Science, Chiesi Farmaceutici SpA, Corestem Inc., Pharmicell Co. Ltd, Fibrocell Technologies Inc., Nipro Corporation, MEDIPOST Co. Ltd, TiGenix (Takeda Pharmaceuticals), and Stempeutics Research Pvt. Ltd.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Cell Therapy Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Cell Therapy Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Cell Therapy Market Segmentation, By Type

• Global Cell Therapy Market Share Analysis, By Type

• Global Cell Therapy Market Growth Analysis, By Type

• Global Cell Therapy Market Trends, By Type

o Autologous

o Allogeneic

6. Global Cell Therapy Market Segmentation, By Therapy

• Global Cell Therapy Market Share Analysis, By Therapy

• Global Cell Therapy Market Growth Analysis, By Therapy

• Global Cell Therapy Market Trends, By Therapy

o Mesenchymal Stem Cell Therapy

o Fibroblast Cell Therapy

o Hematopoietic Stem Cell Therapy

o Other Therapies

7. Global Cell Therapy Market Segmentation, By Application

• Global Cell Therapy Market Share Analysis, By Application

• Global Cell Therapy Market Growth Analysis, By Application

• Global Cell Therapy Market Trends, By Application

o Musculoskeletal

o Malignancies

o Cardiovascular

o Dermatology and Wounds

o Other Applications

8. Global Cell Therapy Market Segmentation, By Region

• Global Cell Therapy Market Share Analysis, By Region

• Global Cell Therapy Market Growth Analysis, By Region

• Global Cell Therapy Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

9. Competitive Landscape

• Anterogen Co. Ltd *

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Tego Science

• Chiesi Farmaceutici SpA

• Corestem Inc.

• Pharmicell Co. Ltd

• Fibrocell Technologies Inc.

• Nipro Corporation

• MEDIPOST Co. Ltd

• TiGenix (Takeda Pharmaceuticals)

• Stempeutics Research Pvt. Ltd

*Similar analysis will be provided for each company listed above.